Figures & data
Figure 1 Histopathological changes of the two group (× 400). (A) Colonic mucosal histology of normal controls (× 400); (B) Colonic mucosal histology of IBS-D patients (× 400). The positive cells were purple and blue. Hematoxylin-eosin (HE) was used for staining in the detection. IBS-D: Diarrhea-predominant irritable bowel syndrome.
![Figure 1 Histopathological changes of the two group (× 400). (A) Colonic mucosal histology of normal controls (× 400); (B) Colonic mucosal histology of IBS-D patients (× 400). The positive cells were purple and blue. Hematoxylin-eosin (HE) was used for staining in the detection. IBS-D: Diarrhea-predominant irritable bowel syndrome.](/cms/asset/70a273f7-a1a6-440c-90e4-bcdc6b5a664d/djir_a_12190174_f0001_c.jpg)
Figure 2 Immunohistochemical results of tryptase-positive MC (× 400). (A): Tryptase-positive mast cell (MC) in the normal subject (× 400); (B) Tryptase-positive MC in the patient with IBS-D (× 400). The positive cells manifested brown or yellow stained.
![Figure 2 Immunohistochemical results of tryptase-positive MC (× 400). (A): Tryptase-positive mast cell (MC) in the normal subject (× 400); (B) Tryptase-positive MC in the patient with IBS-D (× 400). The positive cells manifested brown or yellow stained.](/cms/asset/d36e24e1-32b0-4c01-bca7-8d3ccf3d0096/djir_a_12190174_f0002_c.jpg)
Figure 3 Immunohistochemical results of NPS, NPY, NPY2R and PAR-2 (× 400). (A) NPS in the normal group (× 400); (B) NPS in the IBS-D group (× 400); (C) NPY in the normal group; (D) NPY in the IBS-D group (× 400); (E) NPY2R in the normal group (× 400); (F) NPY2R in the IBS-D group (× 400); (G) PAR-2 in the normal group (× 400); (H) PAR-2 in the IBS-D group (× 400).
![Figure 3 Immunohistochemical results of NPS, NPY, NPY2R and PAR-2 (× 400). (A) NPS in the normal group (× 400); (B) NPS in the IBS-D group (× 400); (C) NPY in the normal group; (D) NPY in the IBS-D group (× 400); (E) NPY2R in the normal group (× 400); (F) NPY2R in the IBS-D group (× 400); (G) PAR-2 in the normal group (× 400); (H) PAR-2 in the IBS-D group (× 400).](/cms/asset/f794ec4c-1095-477b-aa4b-3534eaf76f16/djir_a_12190174_f0003_c.jpg)
Figure 4 Expression of PAR-2 and NPY2R in the two group. (A) NPY2R and PAR-2 protein bands detected by Western blot; (B) The expression of PAR-2 in the IBS-D group was significantly higher than that in the normal group; (C) The expression of NPY2R in the IBS-D group was significantly lower than that in the normal group.*represents p < 0.05 vs Normal.
![Figure 4 Expression of PAR-2 and NPY2R in the two group. (A) NPY2R and PAR-2 protein bands detected by Western blot; (B) The expression of PAR-2 in the IBS-D group was significantly higher than that in the normal group; (C) The expression of NPY2R in the IBS-D group was significantly lower than that in the normal group.*represents p < 0.05 vs Normal.](/cms/asset/c4614518-1c9d-4af1-bd42-143f46297b25/djir_a_12190174_f0004_c.jpg)